The glucose transporter of Trypanosoma brucei procyclic forms was characterized and compared with its bloodstream form counterpart. Measuring the glucose consumption enzymatically, we determined a saturable uptake process of relatively high affinity (K-m = 80 mu M, V-max = 4 nmol min(-1) 10(-8) cells), which showed substrate inhibition at glucose concentrations above 1.5 mM (K-i = 21 mM). Control experiments measuring deoxy-D-[H-3]Glc uptake under zero-trans conditions indicated that substrate inhibition occurred on the level of glycolysis. Temperature-dependent kinetics revealed a temperature quotient of Q(10) = 2.33 and an activation energy of E(a) = 64 kJ mol(-1). As shown by trans-stimulation experiments, glucose uptake was stereospecific for the D isomer, whereas L-glucose was not recognized. Inhibitor studies using either the uncoupler carbonylcyanide-4-(trifluoromethoxy)phenylhydrazone (5 mu M), the H+/ATPase inhibitor N,N'-dicyclohexylcarbodiimide (20 mu M), the ionophor monensin (1 mu M), or the Na+/K+-ATPase inhibitor ouabain (1 mM) showed insignificant effects on transport efficiency. The procyclic glucose transporter was subsequently enriched in a plasma-membrane fraction and functionally reconstituted into proteoliposomes. Using Na+-free conditions in the absence of a proton gradient, the specific activity of D-[C-14]glucose transport was determined as 2.9 nmol min(-1) (mg protein)(-1) at 0.2 mM glucose. From these cumulative results, we conclude that glucose uptake by the procyclic insect form of the parasite occurs by facilitated diffusion, similar to the hexose-transport system expressed in bloodstream forms. However, the markedly higher substrate affinity indicates a differential expression of different transporter isoforms throughout the lifecycle.